{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:11:54Z","timestamp":1790874714437,"version":"4.1.0"},"reference-count":21,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"DOI":"10.1590\/s1678-9946201961012","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T18:45:27Z","timestamp":1550256327000},"source":"Crossref","is-referenced-by-count":5,"title":["Sofosbuvir, ribavirin and pegylated interferon for a daclatasvir-resistent genotype 3 hepatitis C virus: case report and review"],"prefix":"10.1590","volume":"61","author":[{"given":"Marcos","family":"Mucenic","sequence":"first","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajacio Bandeira de Melo","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Augusto","family":"Marroni","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfeu de Medeiros","family":"Fleck Junior","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia","family":"Zanotelli","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Leipnitz","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio Henrique","family":"Meine","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Kiss","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano","family":"Martini","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Soares","family":"Schlindwein","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane Micheli","family":"Costabeber","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Karlinsky Rodrigues","family":"Sacco","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovana","family":"Rossato","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido Pio Cracco","family":"Cantisani","sequence":"additional","affiliation":[{"name":"Irmandade Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2019]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"10668","DOI":"10.3748\/wjg.v20.i31.10668","article-title":"Recurrent hepatitis C after liver transplant","volume":"20","author":"deLemos AS","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jhep.2017.03.006","article-title":"ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients","volume":"67","author":"Belli LS","year":"2017","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL Recommendations on Treatment of Hepatitis C 2015","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/lt.20074","article-title":"Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C","volume":"10","author":"Abdelmalek MF","year":"2004","journal-title":"Liver Transpl"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/j.1600-6143.2005.00976.x","article-title":"Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C","volume":"5","author":"Bizollon T","year":"2005","journal-title":"Am J Transplant"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/j.1600-6143.2008.02362.x","article-title":"Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection","volume":"8","author":"Veldt BJ","year":"2008","journal-title":"Am J Transplant"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/TP.0b013e3181bd783c","article-title":"Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome","volume":"88","author":"Selzner N","year":"2009","journal-title":"Transplantation"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2009.05.016","article-title":"Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C","volume":"51","author":"Bochud PY","year":"2009","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.3390\/v7092864","article-title":"Interferon-free hepatitis C treatment before and after liver transplantation: the role of HCV drug resistance","volume":"7","author":"Roche B","year":"2015","journal-title":"Viruses"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2014.10.001","article-title":"Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation","volume":"148","author":"Charlton M","year":"2015","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","article-title":"An interferon-free antiviral regimen for HCV after liver transplantation","volume":"371","author":"Kwo PY","year":"2014","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/hep.27770","article-title":"Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant","volume":"61","author":"Pungpapong S","year":"2015","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.dld.2014.06.004","article-title":"Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late","volume":"46","author":"Pellicelli AM","year":"2014","journal-title":"Dig Liv Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.transproceed.2018.02.001","article-title":"Daclatasvir and sofosbuvir with or without ribavirin in liver transplant recipients: a single-center real-world study","volume":"50","author":"Mucenic M","year":"2018","journal-title":"Transplant Proc"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2016.05.039","article-title":"Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence \u2013 The ANRS CUPILT study","volume":"65","author":"Coilly A","year":"2016","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1016\/S0168-8278(15)30154-9","article-title":"Daclatasvir, sofosbuvir, and ribavirin combination for HCV patients with advanced cirrhosis or posttransplant recurrence: phase 3 ALLY-1 study","volume":"62","author":"Poordad F","year":"2015","journal-title":"J Hepatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection","volume":"376","author":"Bourli\u00e8re M","year":"2017","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL Recommendations on Treatment of Hepatitis C 2018","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138060","article-title":"Resistance-associated NS5A variants of hepatitis C virus are susceptible to interferon-based therapy","volume":"10","author":"Itakura J","year":"2015","journal-title":"PloS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/cid\/ciw387","article-title":"Effectiveness and safety of sofosbuvir-based regimens for chronic HCV genotype 3 infection: results of the HCV-TARGET Study","volume":"63","author":"Feld JJ","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v61\/1678-9946-rimtsp-61-S1678-9946201961012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T18:42:54Z","timestamp":1579891374000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652019005000501&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":21,"alternative-id":["S0036-46652019005000501"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946201961012","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"article-number":"e12"}}